Literature DB >> 18626715

Long-term functional outcome and risk factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin.

Paul J van Koperen1, Jan Wind, Willem A Bemelman, Roel Bakx, Johannes B Reitsma, J Frederik M Slors.   

Abstract

PURPOSE: This study assessed long-term functional outcome and explored risk factors for fistula recurrence in patients surgically treated for cryptoglandular fistulas.
METHODS: Three hundred ten consecutive patients were surgically treated for perianal fistulas. After exclusion of patients with inflammatory bowel disease or HIV, 179 patients remained. Patients were divided into two groups: those who received fistulotomy for low perianal fistulas and those who received rectal advancement flap for high perianal fistulas. Time to fistula recurrence was the main outcome and Cox proportional hazard models were used to assess the importance of various risk factors. Functional outcome was assessed using the Vaizey and colorectal functional outcome (COREFO) questionnaires.
RESULTS: The median follow-up duration was 76 months (range, 7-134). The 3-year recurrence rate for low perianal fistulas treated by fistulotomy (n = 109) was 7 percent (95 percent confidence interval, 1-13 percent). In high transsphincteric fistulas treated by rectal advancement flap (n = 70), the recurrence rate was 21 percent (95 percent confidence interval, 9-33 percent). In both groups, soiling was reported at 40 percent. None of the seven potential risk factors examined were statistically significant.
CONCLUSIONS: Fistula recurrence rate after fistulotomy was low. No clear risk factors were found. Overall functional outcome in terms of continence was good. However, a substantial amount of patients reported soiling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626715     DOI: 10.1007/s10350-008-9354-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  41 in total

Review 1.  Evaluation and management of perianal abscess and anal fistula: a consensus statement developed by the Italian Society of Colorectal Surgery (SICCR).

Authors:  A Amato; C Bottini; P De Nardi; P Giamundo; A Lauretta; A Realis Luc; G Tegon; R J Nicholls
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

2.  Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas.

Authors:  Hector Guadalajara; Dolores Herreros; Paloma De-La-Quintana; Jacobo Trebol; Mariano Garcia-Arranz; Damian Garcia-Olmo
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

3.  Permacol™ collagen paste injection for the treatment of complex anal fistula: 1-year follow-up.

Authors:  B Fabiani; C Menconi; J Martellucci; I Giani; G Toniolo; G Naldini
Journal:  Tech Coloproctol       Date:  2017-02-16       Impact factor: 3.781

4.  Platelet-rich fibrin sealant as a treatment for complex perianal fistulas: a multicentre study.

Authors:  F J Pérez Lara; A Moreno Serrano; J Ulecia Moreno; J Hernández Carmona; M Ferrer Marquez; L Romero Pérez; A del Rey Moreno; H Oliva Muñoz
Journal:  J Gastrointest Surg       Date:  2014-11-25       Impact factor: 3.452

5.  Operative strategy for fistula-in-ano without division of the anal sphincter.

Authors:  A K Y Fung; G V Card; N P Ross; S R Yule; E H Aly
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

Review 6.  Management of Complex Anal Fistulas.

Authors:  Emily J Bubbers; Kyle G Cologne
Journal:  Clin Colon Rectal Surg       Date:  2016-03

Review 7.  Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review.

Authors:  Jeremy Sugrue; Johan Nordenstam; Herand Abcarian; Amelia Bartholomew; Joel L Schwartz; Anders Mellgren; Philip J Tozer
Journal:  Tech Coloproctol       Date:  2017-06-15       Impact factor: 3.781

Review 8.  Systematic review and meta-analysis of surgical interventions for high cryptoglandular perianal fistula.

Authors:  K W A Göttgens; R R Smeets; L P S Stassen; G Beets; S O Breukink
Journal:  Int J Colorectal Dis       Date:  2014-12-10       Impact factor: 2.571

9.  Adipose-derived stem cells in Crohn's rectovaginal fistula.

Authors:  D García-Olmo; D Herreros; P De-La-Quintana; H Guadalajara; J Trébol; T Georgiev-Hristov; M García-Arranz
Journal:  Case Rep Med       Date:  2010-03-07

10.  Ligation of intersphincteric fistula tract and its modification: Results from treatment of complex fistula.

Authors:  Siripong Sirikurnpiboon; Burin Awapittaya; Paiboon Jivapaisarnpong
Journal:  World J Gastrointest Surg       Date:  2013-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.